Poster (download)

[pdf-embedder url=”https://bgrssb.icgbio.ru/wp-content/uploads/2020/07/33.pdf”]
Irina Siutkina1, Khabarov Dmitriy2, Smagin Alexandr3, Bulichev Pavel4, Demura Alexander5, Inyoshina Alisa6
1Research Institute of Clinical and Experimental Lymрhology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, komarok777@mail.ru
2Research Institute of Clinical and Experimental Lymрhology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, hdv@ngs.ru
3Research Institute of Clinical and Experimental Lymрhology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, asa57@ngs.ru
4Research Institute of Clinical and Experimental Lymрhology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, paulbulychev@gmail.com
5Research Institute of Clinical and Experimental Lymрhology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, dx_@bk.ru
6Novosibirsk State University, V.Zelman Institute for Medicine and Psychology 1, Pirogova str., Novosibirsk , Russia, alisaineshinansk@gmail.com

To assess the dynamics of changes in the blood coagulation system in the perioperative period during uterine artery embolization (EUA) based on monitoring of hemostasis system’s indicators, including TEG, and the tendency (or its absence) to trombosis.